drs. lee, mckay on keynote-b61 for non-clear cell rcc
Published 1 year ago • 69 plays • Length 5:29Download video MP4
Download video MP3
Similar videos
-
5:00
keynote-b61: putting a focus on non-clear cell rcc treatment
-
13:28
keynote-b61 study results and a focus on non-clear cell kidney cancer
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
2:04
keynote-b61: extended follow-up analysis
-
9:05
drs. rini, wallis on a 5-year analysis of keynote-426 for advanced clear cell rcc
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
0:41
#adjuvant #pembrolizumab for #rcc #kidneycancer #cancertreatment #cancer
-
1:23
rana mckay, md, on recent data examining atezolizumab and bevacizumab in nccrcc & sccrcc
-
7:24
keynote-564 - immunotherapy before cancer returns in clear cell rcc
-
4:10
non-clear cell kidney cancer trial updates: calypso and keynote-427
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
1:59
dr rini on the background of a biomarker analysis of keynote-426 in rcc
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
10:51
asco gu24 special: assoc. prof. barata discusses the results of keynote-564 and checkmate-914
-
5:04
keynote-427 cohort b: first-line pembrolizumab monotherapy for advanced non-clear cell renal cel...
-
4:58
researcher comment: the keynote-146/study 111 trial | chung-han lee
-
3:07
pembrolizumab, sabr develop a rapport for oligometastatic rcc | shankar siva
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc